Washington University launches multi-site trial on CARE Tool for cancer cost navigation
A multi-site randomized trial is underway to evaluate the CARE Tool, which assists cancer patients in navigating costs and insurance.
Asset / Drug
Drug and asset intelligence for Washington with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.